Andere talen Propanc Biopharma, Inc.

Aandelen

PPCB

US74346N6022

Beurs gesloten - OTC Markets Andere beurzen 21:56:35 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,00105 ^USD	-12,50%		-21,43%	-90,83%

16/04	Propanc Biopharma, Inc. Ontvangt Certificaat van Verlening voor "Samenstelling van Pro-enzymen voor Kankerbehandeling? octrooi van het Europees Octrooibureau	CI
20/02	Propanc Biopharma, Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Propanc Biopharma : Material Agreement - Form 8-K	22/04
Propanc Biopharma Receives Certificate of Grant for Composition of Proenzymes for Cancer Treatment Patent from European Patent Office	17/04
Propanc Biopharma, Inc. Receives Certificate of Grant for ?Composition of Proenzymes for Cancer Treatment? Patent from European Patent Office	16/04
Propanc Biopharma, Inc. announced that it has received $0.025 million in funding from GS Capital Partners LLC	16/04
Propanc Biopharma's CEO Shares Views on Revolutionizing Cancer Treatment, an inside Look at Drug Development and Strategic Financing	09/04
Propanc Biopharma : Material Agreement - Form 8-K	11/03
Propanc Biopharma, Inc. announced that it has received $0.046875 million in funding	01/03
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study	23/02
Propanc Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	20/02
Propanc Biopharma Receives Certificate of Grant for PRP Foundation Patent from Canadian Intellectual Property Office	16/01
Propanc Biopharma's Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP	14/12
Propanc Biopharma, Inc. announced that it has received $0.135 million in funding	11/12
Propanc Biopharma, Inc. announced that it has received $0.045 million in funding	04/12
Propanc Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	14/11
Propanc Biopharma, Inc. announced that it has received $0.04 million in funding	29-10-23
Propanc Biopharma, Inc. announced that it expects to receive $0.04 million in funding	20-10-23
Propanc Biopharma, Inc. announced that it has received $0.0575 million in funding from GS Capital Partners LLC	16-10-23
Propanc Biopharma, Inc. announced that it expects to receive $0.0575 million in funding from GS Capital Partners LLC	12-10-23
Propanc Biopharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023	28-09-23
Propanc Biopharma, Inc. announced that it has received $0.055 million in funding	31-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Propanc Biopharma, Inc.

Aandelen

PPCB

US74346N6022

Andere talen

Filters